COVID-19 Special Series This episode discusses the work done by The Alzheimer’s Association, an organization focused on providing community education and assistance to all affected by Alzheimer’s disease or other dementias. Our guest details how care and support services have quickly adapted to keep families and loved ones safe, healthy, and connected under quarantine. Guest: Kate Kahles, Program Manager, Alzheimer's Association Wisconsin Chapter
Episode Topics:
Show Notes: To learn more about the Alzheimer’s Association and support services near you go to the Community Resource Finder or call the helpline at 1(800)272-3900. All of the important issues happening right now cannot be fully covered, so we strongly encourage you to go to trusted sources for specific information, such as the U.S. Centers for Disease Control and Prevention, your state and local health department websites. You can also find resources on our website, and that of the Wisconsin Alzheimer's Institute. For other interesting and important stories on the COVID-19 pandemic, I would recommend my colleague at UW Health Jonathan Kohler, MD, MA, of the Surgery Sett podcast who has a special series called The Frontlines of COVID.
Study Shows APOE Gene Affects Hispanic Populations’ Risk of Cognitive Decline Differently to Non-Hispanic Populations
Putting Lecanemab into Practice: A Clinician’s Perspective on the New Alzheimer’s Treatment
Deciding to Donate: Barriers and Benefits of Brain Donations for Diverse Populations
Lecanemab, Clinical Trials, and the Importance of Clinical Meaningfulness
Understanding the Social Determinants of Health and Disparities in Alzheimer’s Research
Take Care of Your MIND: Reviewing the MIND Diet for Healthy Brain Aging
The National Strategy for Diversifying Alzheimer’s Research
The Future of Neuroscience: Early-Career Researchers Named ’One to Watch’ by the Alzheimer’s Association
Studies Look at Generational Differences and Associations between Cognition, Sensory Changes and Blood Biomarkers
Disclosing Alzheimer’s Disease Biomarker Results in Diverse Populations
Difficult but Beneficial Conversations about End-of-Life Care
Caregiving While Black: Dementia Care for Different Racial and Ethnic Groups
Our Evolving Understanding of Mild Cognitive Impairment
A Closer Look at the Lecanemab Clinical Trials
Therapeutic Fibbing: Mastering the Art of Communicating with a Loved One with Dementia
The Future of the Alzheimer’s Association: Interview with Dr. Joanne Pike and Harry Johns
Introducing Lecanemab, the Latest Alzheimer’s Disease Drug to Receive FDA Accelerated Approval
Healthy Habits for the New Year and Modifiable Risk Factors for Alzheimer’s Disease
Bioenergetics: How Mitochondria Affects Alzheimer’s Disease and Aging
Looking Toward the Future: How Preclinical Alzheimer’s Disease Biomarker Disclosures Impact Society
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Life in the A-Zone
Caregiver Storyteller - About Alzheimer’s and Dementia Caregiving
The Life, Love, and Alzheimer’s Podcast
Fading Memories: Alzheimer’s/Dementia Caregiver Support
Alzheimer’s Speaks